Universal pennystocks.com focus is on Hot Penny Stocks that trade on OTCBB and OTC markets, which are mostly referred to as “penny stocks”. These Penny Stocks could offer the greatest potential return on your short or long term investment. Sign up for our free newsletter before you miss the next alert.Amgen, Inc. (NASDAQ:AMGN) ended higher by 1.00 points or 1.17% to complete the day at 86.59. The total number of shares changed hands during the day was 21.50 million. After opening at $85.00, the stock hit as high as $87.89. However, it traded between $65.37 and$90.81 over the last twelve months. Amgen Inc., a biotechnology medicines company, discovers, develops, manufactures, and markets human therapeutics based on advances in cellular and molecular biology for grievous illnesses primarily in the United States, Europe, and Canada.
Gilead Sciences, Inc. (NASDAQ:GILD) closed yesterday at $39.90, a 1.17% increase. Around 8.43 million shares were traded, down from an-average trading volume of 8.72 million shares. The company is now valued at around $60.46 billion. Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes human therapeutics for the treatment of life threatening diseases worldwide.
Anacor Pharmaceuticals Inc (NASDAQ:ANAC) moved -20.50 per cent lower at $4.11 and traded between $3.95 and $4.39 after opening the day at $4.00. Its performance over the last five days remained -17.64%, which stands at -19.09% for a month. Going back further than one month, 1-year performance after recent close was -43.47%.Anacor Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing small-molecule therapeutics derived from boron chemistry platform.
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) shares decline, dropping -2.45per cent to close at $8.35. The stock is down around -7.43% this year and 425.16% for the last 12 months. Around 5.42 million shares changed hands yesterday lower from an-average trading volume of 11.53million shares. Arena Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in discovering, developing, and commercializing oral drugs that target G protein-coupled receptors in the therapeutic areas of cardiovascular, central nervous system, inflammatory, and metabolic diseases.
The share price of AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) after ranging between $2.74 and $3.45 ended 17.45% higher to settle at $3.23.During the past 52 weeks, the stock has ranged from a high of $13.00 to a low of $1.75.So far this year, shares have gained 35.71% and 1-year performance was around -67.17%.Aeterna Zentaris Inc., a late-stage biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for oncology and endocrine therapy primarily in the United States, Switzerland, and Japan.
Want to Learn How to Trade Penny Stocks? Click Here and Join Best Penny Stock Newsletter.
See More Updates on Our Blog:http:/universalpennystocks.com/blog/index.php
About Universal Penny Stocks
universalpennystocks.com is an Independent Company, our focus is on small cap stocks that trade on OTCBB and OTC markets, and are mostly referred to as “penny stocks”. These are stocks that normally trade under $5 a share and could offer the greatest potential return on your short or long term investment. You must read our Disclaimer page for more information regarding conflicts of interest and the risks involved.
We try to spot stocks in all types of market conditions. In addition, we provide emerging small cap companies with profiling and investor relations services for compensation. If you believe your company is an emerging company, with a solid product, or a company that offers our members a profitable short or long term opportunity please feel free to send us an e-mail and we’ll review the company and reply to your inquiry promptly. Please provide as much information you believe we’ll need to review your request.